We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF

7 hedge funds and large institutions have $63.5M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95.77% more ownership

Funds ownership: 0%95.77% (+96%)

Holders
7
Holders Change
+7
Holders Change %
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
1
Bank of America
North Carolina
$10.4M +$10.2M +400,000 New
Morgan Stanley
2
Morgan Stanley
New York
$10.4M +$10.2M +400,000 New
JP Morgan Chase
3
JP Morgan Chase
New York
$10.4M +$10.2M +399,997 New
Citigroup
4
Citigroup
New York
$10.4M +$10.2M +400,000 New
CS
5
Credit Suisse
Switzerland
$10.4M +$10.2M +400,000 New
TRCT
6
Tower Research Capital (TRC)
New York
$8.44M +$8.28M +325,629 New
Mirae Asset Global Investments
7
Mirae Asset Global Investments
South Korea
$3.26M +$3.21M +126,000 New

IBBQ Hedge Fund Activity: Q2 2021 in Review

7 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2021, worth a combined $63.5M.

Buyers outnumbered sellers: 7 funds opened new IBBQ positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $10.2M.

  • 7 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $63.5M of Invesco NASDAQ Biotechnology ETF stock for Q2 2021.
  • 7 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2021 and 0 closed out, a net change of +7 holders.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2021 was Bank of America, an estimated $10.2M added.

Based on aggregated 13F filings for Q2 2021.